Follow Us On

Facebook  X  Linkedin  YouTube
 
 

We celebrated the extension of Telehealth through next year. During the legislative process and our advocacy efforts, the understanding was that Telehealth flexibilities would continue as they had in previous years. However, a significant change was made that has caught many organizations and practitioners by surprise.


For the past several years, CMS allowed physicians and other practitioners to provide Telehealth services from their homes while billing under their group’s practice address. That flexibility ended on January 1, 2026.


Effective January 1, 2026, physicians and other practitioners must separately enroll each location from which they provide Telehealth services. According to CMS, “virtual-only telehealth practitioners whose only physical practice location is their home address will need to enroll their home address as a practice location.”


This means that:

  • If you are currently billing for Telehealth services provided from your home while using your group’s practice address, you should discontinue this practice unless your home location has been appropriately enrolled.


  • If you provide Telehealth services in multiple states, you may face significant enrollment and update backlogs, particularly if you intend to enroll multiple practice locations for each physician and other practitioners within your organization.


We encourage all practices to review their Telehealth billing and enrollment processes to ensure compliance with the updated CMS requirements.


Click here to read the updated Telehealth CMS requirements.

 
 

Advance Your Skills at

ASIPP’s Hands-On Workshops

Join ASIPP this August at the Medical Education & Research Institute (MERI) in Memphis, Tennessee for three hands-on educational workshops:


  • Ultrasound for Regenerative Medicine Hands-On Workshop
  • Regenerative Medicine Hands-On Cadaver Workshop
  • Interventional Techniques in IPM Hands-On Cadaver Workshop
  • Peripheral Nerve Stimulation Hands-On Workshop
  • Intradiscal Nucleus Pulpous Procedure Hands-On Workshop



Each workshop offers attendees the opportunity to earn 8 CME credits while participating in practical, hands-on instruction. Attendees who participate in the Friday workshop and one Saturday workshop may earn up to 16 CMEs.


ACCOMMODATIONS

The Westin Memphis, Beale Street

170 Lt. George W Lee Ave, Memphis, TN 38103

901-334-5900


Click Here to Book Your Room

Cut-off date for special room rates: August 13, 2026.

In order to ensure you receive the discounted room block rate of $189 plus tax per night let the hotel know you are with the ASIPP workshops.


Space is limited for these workshops.

Early registration is encouraged.

FRIDAY, AUGUST 28



Ultrasound for Regenerative Medicine Hands-On Workshop



Earn 8 CMEs while gaining practical ultrasound experience focused on regenerative medicine applications.


SATURDAY, AUGUST 29



Regenerative Medicine Hands-On Cadaver Workshop

(Basic, Intermediate, & Advanced)



Earn 8 CMEs in this cadaver workshop with hands-on instruction covering regenerative medicine techniques across varying experience levels.

SATURDAY, AUGUST 29



Interventional Techniques in IPM Hands-On Cadaver Workshop

(Basic, Intermediate & PNS)


Earn 8 CMEs in this workshop focused on interventional pain management techniques and peripheral nerve stimulation applications.

Private Medicare Denies Long-Term and Rehab Care at Exceedingly High Rates

UnitedHealthcare, CVS Health, and Humana had the highest denial rates



An HHS Office of Inspector General (OIG) report found that among 19 Medicare Advantage organizations, the three largest denied prior authorization requests for care in long-term care hospitals (LTCHs) and inpatient rehabilitation facilities (IRFs) at higher rates than most of their peers.


"In some cases, high denial rates were driven by contractors that denied prior authorization requests on behalf of the MA [Medicare Advantage] organizations, many of which were later overturned on appeal by the [organization]," the investigators noted. "This raises concerns about whether contractors are receiving appropriate training and oversight from MA organizations."


Overall, the 19 plans in June 2024 denied 65% of LTCH prior authorization requests and 54% of IRF requests. For the LTCH requests, denial rates varied widely, with CVS Health denying 80% of requests, Humana 72%, and UnitedHealthcare 71%, while the University of Pittsburgh Medical Center Health System denied 8% of requests. And for IRF requests, the three large insurers again led the pack, with denial rates of 51%, 54%, and 66%, respectively.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.

Five Things I Wish Someone Said at My 1998 Medical School Graduation 

By Mary Meyer MD, MPH


No one will ever care again what your class rank was


Around this time of year, medical schools are engaging in a 250-year-old annual tradition: they're graduating their latest class of career-ready physicians. It's a deservedly triumphant moment -- the culmination of at least a decade's worth of determination, discipline, and grit.


Almost three decades ago, I, too, was a medical school graduate. I walked across the stage, was handed a rolled-up diploma, and was told I was a physician. I had chosen a new speciality -- emergency medicine -- predicated on the idea that all patients deserve high-quality life-saving care, regardless of background or ability to pay. Our keynote speaker delivered a speech about medicine's illustrious history and intoxicating future, and the overall sentiment was that medicine could accomplish just about anything.


Today, I'm twice as old as I was when I graduated, with my own share of battle scars and a career path that was anything but linear. In the years since graduation, I've sometimes found myself wondering what I would tell a new physician about a career in medicine. For that matter, what did my 1998 self need to know to survive the next 30 years?


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!


FDA Staff Weigh In on Potential First mRNA Flu Shot 

Moderna's novel vaccine was at the center of dustup with agency earlier this year


Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's mRNA flu vaccine candidate for adults 50 and older, which has the potential to become the first such product approved by the agency.


The trivalent influenza vaccine (mRNA-1010) is the one FDA controversially refused to consider earlier this year amid questions about the pivotal study's control arm.


In the Fluent randomized trial, the vaccine -- which targets influenza A/H1N1, A/H3N2, and B/Victoria -- outperformed standard flu shots among adults 50 and older, with a relative vaccine efficacy of 26.6%. Among Fluent's more than 19,000 adults 65 and older, the mRNA shot's relative vaccine efficacy was 27.4%.


In briefing documents released ahead of the Thursday meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), FDA reviewers questioned whether comparing the mRNA vaccine against standard-dose flu shots is adequate and clinically meaningful in adults 65 or older, given that high-dose, recombinant, or adjuvanted vaccines are recommended in that age group.


Click here to read the full article.



Cannabis Psychosis Shows Distinct Symptom Pattern




Cannabis-associated psychosis (CAP) is associated with better cognitive function, lower cortical excitatory or inhibitory balance, fewer negative symptoms, and greater reductions in mood symptoms than non-CAP, a new study showed.


METHODOLOGY:

  • A prospective, longitudinal, observational study conducted in India included 66 men (mean age, 27 years) hospitalized for new-onset psychosis associated with confirmed cannabis exposure and 53 matched men (mean age, 30 years) hospitalized for new-onset non-CAP.
  • At admission and after 4 weeks of standardized inpatient treatment, the participants were assessed using the CogState Schizophrenia Battery and Hopkins Verbal Learning Test (HVLT), EEG, the Positive and Negative Syndrome Scale (PANSS), the Calgary Depression Rating Scale, and the Young Mania Rating Scale.
  • Cannabis exposure was confirmed via patient self-report, information obtained from family members, structured interviews, and urine toxicology.
  • Outcomes included cognitive test performance, EEG measures of cortical excitatory or inhibitory balance, and symptom scores for psychosis.


Click here to read the full article.


Apply now for one of the following 2026 dates:


June 27, July 25, September 26, October 24, November 14,

& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam


August 28, 2026


  • ABIPP Part II Oral and Practical Examination

Topics that will be covered:

Caudal epidural injections; Lumbar interlaminar epidural injections; Lumbar/sacral transforaminal epidural injections; Cervical epidural injections; Thoracic epidural injections; Lumbar/sacral medial branch and L5 dorsal ramus blocks; Cervical medial branch blocks; Thoracic medial branch blocks; Lumbar/sacral facet joint nerve radiofrequency neurolysis; Cervical medial branch radiofrequency neurolysis; Thoracic medial branch radiofrequency neurolysis; Sacroiliac joint injections; Cervical sympathetic blocks; Lumbar paravertebral sympathetic blocks; Intercostal nerve blocks; Lumbar discography; Celiac plexus blocks (not Splancnic nerve blocks); Percutaneous epidural adhesiolysis; Spinal cord stimulation lead placement

Exam Dates

Our Sponsor




Speech-Analyzing AI Flags Early Cognitive Impairment 



While a primary care clinician meets with a patient for their annual check-up, an AI model analyzes the patients’ speech patterns for signs of cognitive impairment. Such a screening could be possible within the next few years, according to a recent feasibility study published in JAMA Neurology.


Researchers tested how well machine learning algorithms analyze conversational speech patterns to identify red flags for potential dementia or Alzheimer’s cases — one model accurately identified about 30% of patients who had cognitive impairment.


“While the clinical note is being generated, all of the information that we use in our algorithm is also captured during that process, just listening to the conversation,” said Joseph Colonel, PhD, a postdoctoral research fellow at the Icahn School of Medicine at Mount Sinai in New York City, who led the study. “All the pieces are there so that at the end of the doctor’s visit, there could be a risk score that goes up [in the patient’s chart] and says, you might want to consider that this person should be screened for cognitive impairment.”


Click here to read the full article.

Our Sponsor

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Exosome-Rich Mesenchymal Stem Cell Secretome Improves Symptoms From Parkinson’s Disease: A Case Series


Chadwick C. Prodromos, MD, Ruby Del Villar, MS, Drew Gura , and Kenneth D. Candido, MD

Thoracic Botox Injections for Refractory Notalgia Paresthetica


Parker Nguyen, MD, Rebecca Cox, MD, Ahish Chitneni, DO, and Nasser Ayyad, DO

Temporary Occipital Nerve Peripheral Nerve Stimulation at C2 in Refractory Occipital Pain: Case Series


Hesham Elsharkawy, MD, Nicolas M. Mas D. Alessandro, MD, Shaarav Ghose, BA, and Faria Nisar, MD

 

New Issue!

 

SCOPING REVIEW

Sympathetic and Parasympathetic Ganglion Blocks for Treatment of Long COVID-19 Symptoms: A Scoping Review


Abhay Tyagi, MBBS, MD, Khushboo Singh, MD, Preet Mohinder Singh, MD, and Frederic J. Gerges, MD

PERSPECTIVE

Match Program Signaling in Pain Medicine Fellowship Applications: Association with Interview Outcomes and Implications for a Shrinking Applicant Pipeline


Alexander Bautista, MD, Meredith Barad, MD, Trent D. Emerick, MD, Yashar Eshraghi, MD, Prentiss Lawson, MD, Saba Javed, MD, Tolga Suvar, MD, Christine Oryhan, MD, Thelma Wright, MD, JD, and Kristen Noon, MD

CROSS-SECTIONAL STUDY

Artificial Intelligence in Interventional Pain: Can ChatGPT Match Fellowship-Level Expertise?: A Comparative Analysis of Accuracy and Readability


Merve Sekizkardes, Savas Sencan, Serdar Kokar, and Osman Hakan Gunduz




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!